3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
39
Leukemia
16
Congenital Abnormalities
10
Leukemia, Monocytic, Acute
8
Leukemia, Myelomonocytic, Acute
7
Leukemia, Megakaryoblastic, Acute
6
Leukemia, Erythroblastic, Acute
6
Myelodysplastic Syndromes
5
Recurrence
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Eosinophilic, Acute
3
Anemia, Refractory, with Excess of Blasts
3
Leukemia, Promyelocytic, Acute
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Basophilic, Acute
2
Neoplasms
1
Myeloproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Liver Neoplasms
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Biphenotypic, Acute
1
Childhood Acute Promyelocytic Leukemia With PML-RARA
1
Interventions
fludarabine phosphate
18
Peripheral Blood Stem Cell Transplantation
15
Whole-Body Irradiation
14
Mycophenolic Acid
14
Cyclophosphamide
14
Tacrolimus
10
Cyclosporine
10
Busulfan
10
Antilymphocyte Serum
10
Methotrexate
8
Melphalan
7
Etoposide
7
Sirolimus
5
Radiotherapy
5
Filgrastim
5
Cord Blood Stem Cell Transplantation
5
Granulocyte Colony-Stimulating Factor
4
Cytarabine
4
Cyclosporins
4
thymoglobulin
3
Methylprednisolone
3
Therapeutics
2
Rituximab
2
Ondansetron
2
Flow Cytometry
2
Dexamethasone
2
Carmustine
2
Carboplatin
2
Calcium Dobesilate
2
Aprepitant
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
×
Idarubicin
×
Clear all
No trials found.